Bessemer Group Inc Bio Rad Laboratories, Inc. Transaction History

Bessemer Group Inc

  • $60.7 Billion
  • Q3 2024

A detailed history of Bessemer Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 109 shares of BIO stock, worth $36,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109
Previous 20 445.0%
Holding current value
$36,812
Previous $5,000 620.0%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$263.97 - $344.64 $23,493 - $30,672
89 Added 445.0%
109 $36,000
Q2 2024

Aug 13, 2024
BUY
$268.26 - $339.48 $2,414 - $3,055
9 Added 81.82%
20 $5,000
Q1 2024

May 13, 2024
BUY
$304.11 - $351.99 $1,824 - $2,111
6 Added 120.0%
11 $4,000
Q4 2023

Feb 09, 2024
SELL
$269.37 - $365.04 $95,087 - $128,859
-353 Reduced 98.6%
5 $2,000
Q3 2023

Nov 13, 2023
SELL
$350.25 - $422.63 $7,355 - $8,875
-21 Reduced 5.54%
358 $128,000
Q2 2023

Aug 10, 2023
SELL
$359.49 - $486.4 $38,465 - $52,044
-107 Reduced 22.02%
379 $144,000
Q1 2023

May 10, 2023
SELL
$418.69 - $503.0 $23,027 - $27,665
-55 Reduced 10.17%
486 $232,000
Q4 2022

Feb 13, 2023
BUY
$351.71 - $456.01 $1,055 - $1,368
3 Added 0.56%
541 $227,000
Q3 2022

Nov 09, 2022
BUY
$412.59 - $563.26 $17,741 - $24,220
43 Added 8.69%
538 $225,000
Q2 2022

Aug 10, 2022
SELL
$463.67 - $597.16 $486,853 - $627,018
-1,050 Reduced 67.96%
495 $245,000
Q1 2022

May 12, 2022
BUY
$524.57 - $735.42 $205,106 - $287,549
391 Added 33.88%
1,545 $870,000
Q4 2021

Jan 27, 2022
BUY
$708.84 - $794.68 $163,742 - $183,571
231 Added 25.03%
1,154 $872,000
Q3 2021

Nov 12, 2021
BUY
$657.71 - $825.77 $19,731 - $24,773
30 Added 3.36%
923 $688,000
Q2 2021

Aug 06, 2021
SELL
$576.64 - $649.04 $26,525 - $29,855
-46 Reduced 4.9%
893 $575,000
Q1 2021

May 13, 2021
SELL
$547.01 - $662.35 $416,821 - $504,710
-762 Reduced 44.8%
939 $536,000
Q4 2020

Feb 09, 2021
BUY
$510.68 - $643.45 $360,540 - $454,275
706 Added 70.95%
1,701 $992,000
Q3 2020

Nov 12, 2020
SELL
$454.43 - $535.6 $761,170 - $897,130
-1,675 Reduced 62.73%
995 $513,000
Q2 2020

Aug 05, 2020
BUY
$334.87 - $493.06 $743,411 - $1.09 Million
2,220 Added 493.33%
2,670 $1.21 Million
Q1 2020

Apr 30, 2020
BUY
$320.01 - $409.07 $119,683 - $152,992
374 Added 492.11%
450 $158,000
Q4 2019

Feb 04, 2020
BUY
$319.73 - $374.2 $14,068 - $16,464
44 Added 137.5%
76 $28,000
Q3 2019

Nov 07, 2019
BUY
$304.55 - $345.24 $9,745 - $11,047
32 New
32 $11,000
Q1 2019

May 13, 2019
SELL
$224.3 - $317.41 $4,037 - $5,713
-18 Closed
0 $0
Q4 2018

Feb 12, 2019
BUY
$220.1 - $309.0 $3,961 - $5,562
18 New
18 $4,000

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.32B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email